These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10193446

  • 1. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ, Holmes BB, Fujimoto JM.
    Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
    [Abstract] [Full Text] [Related]

  • 2. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
    Holmes BB, Rady JJ, Smith DJ, Fujimoto JM.
    Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
    [Abstract] [Full Text] [Related]

  • 3. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
    Rady JJ, Lin W, Fujimoto JM.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):878-85. PubMed ID: 9495845
    [Abstract] [Full Text] [Related]

  • 4. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
    Fujimoto JM, Arts KS, Rady JJ, Tseng LF.
    Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
    [Abstract] [Full Text] [Related]

  • 5. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
    Rady JJ, Holmes BB, Tseng LF, Fujimoto JM.
    J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
    [Abstract] [Full Text] [Related]

  • 6. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
    Fujimoto JM, Holmes B.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
    [Abstract] [Full Text] [Related]

  • 7. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 8. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW, Kim YH, Choi YS, Song DK.
    Peptides; 1995 Dec; 16(7):1229-34. PubMed ID: 8545243
    [Abstract] [Full Text] [Related]

  • 9. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
    Holmes BB, Fujimoto JM.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
    [Abstract] [Full Text] [Related]

  • 10. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [Abstract] [Full Text] [Related]

  • 11. Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
    Rady JJ, Campbell WB, Fujimoto JM.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):7-14. PubMed ID: 11123356
    [Abstract] [Full Text] [Related]

  • 12. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice.
    Rady JJ, Fujimoto JM.
    J Pharmacol Exp Ther; 2001 Nov; 299(2):659-65. PubMed ID: 11602679
    [Abstract] [Full Text] [Related]

  • 13. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
    Rady JJ, Fujimoto JM.
    Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
    [Abstract] [Full Text] [Related]

  • 14. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
    Rady JJ, Holmes BB, Fujimoto JM.
    Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
    [Abstract] [Full Text] [Related]

  • 15. Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
    Aksu F, Holmes BB, Fujimoto JM.
    Pharmacol Biochem Behav; 1993 Jun; 45(2):409-18. PubMed ID: 8101007
    [Abstract] [Full Text] [Related]

  • 16. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [Abstract] [Full Text] [Related]

  • 17. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
    Rady JJ, Fujimoto JM.
    Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
    [Abstract] [Full Text] [Related]

  • 18. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ, Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [Abstract] [Full Text] [Related]

  • 19. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin.
    Arts KS, Fujimoto JM, Crain SM.
    Pharmacol Biochem Behav; 1993 Nov 21; 46(3):623-9. PubMed ID: 7904072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.